Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2011; 05(03): 337-339
DOI: 10.1055/s-0039-1698901
Original Article
Dental Investigation Society

Resolution of Anterior Scleritis after Periodontal Therapy

Guliz Nigar Guncu
a   Department of Periodontology, Faculty of Dentistry, Hacettepe University, Ankara, Turkey.
,
Feriha Caglayan
a   Department of Periodontology, Faculty of Dentistry, Hacettepe University, Ankara, Turkey.
› Author Affiliations
Further Information

Publication History

Publication Date:
30 September 2019 (online)

  PDF Download Permissions and Reprints

ABSTRACT

Scleritis is a chronic inflammation that involves the outermost coat and the skeleton of the eye. Scleritis may be associated with a systemic or immune mediated disease and it might be caused by an infection, trauma or drug reaction. This case presents a patient with generalized chronic periodontitis and anterior diffuse scleritis. A 30-year-old female complained of pain and persistent scleritis in the left eye was referred to the Periodontology department due to her periodontal problems. She was treated with oral non steroidal anti-inflammatory drugs and topical medications (corticosteroid) for her scleritis during last two years. However, these treatments failed to control the progression of the disease. After periodontal examination, deep periodontal pockets and serious bone loss was detected radiographically. She was treated by flap procedures and 3 teeth were extracted. After a 4-month healing period, scleritis was resulted in rapid resolution. (Eur J Dent 2011;5:337-339)

Key words:

Anterior scleritis - Periodontitis - Treatment
 

  • REFERENCES

  • 1 Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 2007;3:219-226.
  • 2 Watson PG, Hayreh SS, Awdry PN. Episcleritis and scleritis. I. Br J Ophthalmol 1968;52:278-279.
  • 3 Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol 1976;60:163-191.
  • 4 Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol 2001;12:471- 478.
  • 5 Ghanchi FD, Rembacken BJ. Inflammatory bowel disease and the eye. Surv Ophthalmol 2003;48:663-676.
  • 6 Knox DL, Schachat AP, Mustonen E. Primary, secondary and coincidental ocular complications of Crohn's disease. Ophthalmology 1984;91:163-173.
  • 7 Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000 2001;25:21-36.
  • 8 Papapanou PN, Sandros J, Lindberg K, Duncan MJ, Niederman R, Nannmark U. Porphyromonas gingivalis may multiply and advance within stratified human junctional epithelium in vitro. J Periodontal Res 1994;29:374-375.
  • 9 Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009;36 Suppl 10:15-19.
  • 10 Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005;50:351-363.
  • 11 Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.
  • 12 D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-160.